Sun Pharma Advanced Research Company has informed that a meeting of the Board of Directors of the Company will be held on March 05, 2016, to fix the Issue Price, Issue Size, Rights Entitlement Ratio, Fractional Entitlement and Record Date / Book Closure Dates for determining eligibility of the shareholders to whom the equity shares are to be issued under the proposed Rights Issue of the Company. Further, in view of the above the trading window for of dealing with equity shares of the Company by the Designated Persons has been closed with immediate effect and shall continue to remain closed until March 09, 2016.
The above information is a part of company’s filings submitted to BSE.
